188 related articles for article (PubMed ID: 26843623)
1. Distinguishing epigenetic features of preneoplastic testis tissues adjacent to seminomas and nonseminomas.
Gainetdinov IV; Kondratieva SA; Skvortsova YV; Zinovyeva MV; Stukacheva EA; Klimov A; Tryakin AA; Azhikina TL
Oncotarget; 2016 Apr; 7(16):22439-47. PubMed ID: 26843623
[TBL] [Abstract][Full Text] [Related]
2. Assessment of piRNA biogenesis and function in testicular germ cell tumors and their precursor germ cell neoplasia in situ.
Gainetdinov IV; Skvortsova YV; Kondratieva SA; Klimov A; Tryakin AA; Azhikina TL
BMC Cancer; 2018 Jan; 18(1):20. PubMed ID: 29301509
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of hiwi, a human member of the piwi gene family whose overexpression is correlated to seminomas.
Qiao D; Zeeman AM; Deng W; Looijenga LH; Lin H
Oncogene; 2002 Jun; 21(25):3988-99. PubMed ID: 12037681
[TBL] [Abstract][Full Text] [Related]
4. AZFa protein DDX3Y is differentially expressed in human male germ cells during development and in testicular tumours: new evidence for phenotypic plasticity of germ cells.
Gueler B; Sonne SB; Zimmer J; Hilscher B; Hilscher W; Græm N; Rajpert-De Meyts E; Vogt PH
Hum Reprod; 2012 Jun; 27(6):1547-55. PubMed ID: 22466863
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of HENMT1 and PIWIL1 in human testis: implications for transposon expression.
Hempfling AL; Lim SL; Adelson DL; Evans J; O'Connor AE; Qu ZP; Kliesch S; Weidner W; O'Bryan MK; Bergmann M
Reproduction; 2017 Oct; 154(4):363-374. PubMed ID: 28676534
[TBL] [Abstract][Full Text] [Related]
6. Is a CIS phenotype apparent in children with Disorders of Sex Development? Milder testicular dysgenesis is associated with a higher risk of malignancy.
Chemes HE; Venara M; Del Rey G; Arcari AJ; Musse MP; Papazian R; Forclaz V; Gottlieb S
Andrology; 2015 Jan; 3(1):59-69. PubMed ID: 25598272
[TBL] [Abstract][Full Text] [Related]
7. High-resolution telomere fluorescence in situ hybridization reveals intriguing anomalies in germ cell tumors.
Shekhani MT; Barber JR; Bezerra SM; Heaphy CM; Gonzalez Roibon ND; Taheri D; Reis LO; Guner G; Joshu CE; Netto GJ; Meeker AK
Hum Pathol; 2016 Aug; 54():106-12. PubMed ID: 27085557
[TBL] [Abstract][Full Text] [Related]
8. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.
Honorio S; Agathanggelou A; Wernert N; Rothe M; Maher ER; Latif F
Oncogene; 2003 Jan; 22(3):461-6. PubMed ID: 12545168
[TBL] [Abstract][Full Text] [Related]
9. Distinctive epigenetic phenotype of cancer testis antigen genes among seminomatous and nonseminomatous testicular germ-cell tumors.
Zhang C; Kawakami T; Okada Y; Okamoto K
Genes Chromosomes Cancer; 2005 May; 43(1):104-12. PubMed ID: 15672408
[TBL] [Abstract][Full Text] [Related]
10. Involvement of epigenetic modifiers in the pathogenesis of testicular dysgenesis and germ cell cancer.
Lawaetz AC; Almstrup K
Biomol Concepts; 2015 Jun; 6(3):219-27. PubMed ID: 26103631
[TBL] [Abstract][Full Text] [Related]
11. In Search of TGCT Biomarkers: A Comprehensive
Raos D; Krasic J; Masic S; Abramovic I; Coric M; Kruslin B; Katusic Bojanac A; Bulic-Jakus F; Jezek D; Ulamec M; Sincic N
Dis Markers; 2020; 2020():8841880. PubMed ID: 33224314
[TBL] [Abstract][Full Text] [Related]
12. Frequent epigenetic inactivation of p53 target genes in seminomatous and nonseminomatous germ cell tumors.
Christoph F; Kempkensteffen C; Weikert S; Krause H; Schostak M; Miller K; Schrader M
Cancer Lett; 2007 Mar; 247(1):137-42. PubMed ID: 16697107
[TBL] [Abstract][Full Text] [Related]
13. [Expression levels of the IAP antagonists XAF1, Smac/DIABLO and HtrA2 in testicular germ cell tumours].
Kempkensteffen C; Hinz S; Jäger T; Weikert S; Krause H; Schostak M; Christoph F; Strenziok R; Miller K; Schrader M
Aktuelle Urol; 2008 Nov; 39(6):436-41. PubMed ID: 18979398
[TBL] [Abstract][Full Text] [Related]
14. Aneuploidy of human testicular germ cell tumors is associated with amplification of centrosomes.
Mayer F; Stoop H; Sen S; Bokemeyer C; Oosterhuis JW; Looijenga LH
Oncogene; 2003 Jun; 22(25):3859-66. PubMed ID: 12813459
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development.
Skotheim RI; Lind GE; Monni O; Nesland JM; Abeler VM; Fosså SD; Duale N; Brunborg G; Kallioniemi O; Andrews PW; Lothe RA
Cancer Res; 2005 Jul; 65(13):5588-98. PubMed ID: 15994931
[TBL] [Abstract][Full Text] [Related]
16. Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors.
Smiraglia DJ; Szymanska J; Kraggerud SM; Lothe RA; Peltomäki P; Plass C
Oncogene; 2002 May; 21(24):3909-16. PubMed ID: 12032829
[TBL] [Abstract][Full Text] [Related]
17. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.
Biermann K; Göke F; Nettersheim D; Eckert D; Zhou H; Kahl P; Gashaw I; Schorle H; Büttner R
J Pathol; 2007 Nov; 213(3):311-8. PubMed ID: 17768701
[TBL] [Abstract][Full Text] [Related]
18. Differences in global DNA methylation of testicular seminoma are not associated with changes in histone modifications, clinical prognosis, BRAF mutations or gene expression.
Pedersen LH; Nielsen JE; Daugaard G; Hansen TV; Rajpert-De Meyts E; Almstrup K
Cancer Genet; 2016 Nov; 209(11):506-514. PubMed ID: 27886677
[TBL] [Abstract][Full Text] [Related]
19. Deregulation of EZH2 expression in human spermatogenic disorders and testicular germ cell tumors.
Hinz S; Magheli A; Weikert S; Schulze W; Krause H; Schrader M; Miller K; Kempkensteffen C
World J Urol; 2010 Oct; 28(5):631-5. PubMed ID: 20043168
[TBL] [Abstract][Full Text] [Related]
20. Association Study between Polymorphisms in DNA Methylation-Related Genes and Testicular Germ Cell Tumor Risk.
Grasso C; Popovic M; Isaevska E; Lazzarato F; Fiano V; Zugna D; Pluta J; Weathers B; D'Andrea K; Almstrup K; Anson-Cartwright L; Bishop DT; Chanock SJ; Chen C; Cortessis VK; Dalgaard MD; Daneshmand S; Ferlin A; Foresta C; Frone MN; Gamulin M; Gietema JA; Greene MH; Grotmol T; Hamilton RJ; Haugen TB; Hauser R; Karlsson R; Kiemeney LA; Lessel D; Lista P; Lothe RA; Loveday C; Meijer C; Nead KT; Nsengimana J; Skotheim RI; Turnbull C; Vaughn DJ; Wiklund F; Zheng T; Zitella A; Schwartz SM; McGlynn KA; Kanetsky PA; Nathanson KL; Richiardi L
Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1769-1779. PubMed ID: 35700037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
